Erik Wilms

Has grant

Head of Laboratory

Netherlands

Research Interests

Explore related searches

Professors in Netherlands

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Erik Wilms is the Head of Laboratory at Apotheek Haagse Ziekenhuizen in the Netherlands. His research primarily focuses on pharmacokinetics, drug-drug interactions, and contamination in parenteral fluids. Recent publications reflect his expertise in optimizing dosages for patients with renal insufficiency and evaluating safety in drug interactions among diverse patient populations.

Recent Grants

Grant: Close

“Incidence and predictors of rapid response to Remdesivir in COVID-19 patients: a retrospective cohort study”

Open Date: 2020-07-01

Close Date: 2022-12-01

Articles (11)

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Collaborators (4)

Cees van Nieuwkoop

Associate professor

Leiden University Medical Center

NETHERLANDS

View details

Eleonora Swart

Head of Department

Amsterdam UMC Locatie AMC

NETHERLANDS

View details

Brenda de Winter

Hospital Pharmacist - Assistant Professor

Erasmus University Medical Center

NETHERLANDS

View details

Frederiek van den Bos

internist-geriatrician, associate professor

Leiden University Medical Center

NETHERLANDS

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Erik Wilms

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (11)

Particulate contamination in parenteral fluid from glass ampoules: compliance assessment and comparative analysis of needle types and ampoule-breaking strategies

Population Pharmacokinetics of Trimethoprim/Sulfamethoxazole: Dosage Optimization for Patients with Renal Insufficiency or Receiving Continuous Renal Replacement Therapy

Examination of Particulate Contamination in Parenteral Injections and Infusions Following Fluid Withdrawal Utilizing Conventional Needles and Filter Needles: Assessment of Compliance and Comparative Analysis

Evaluation of the drug–drug interaction between triazole antifungals and cystic fibrosis transmembrane conductance regulator modulators in a real-life cohort

Elexacaftor/tezacaftor/ivacaftor in liver or kidney transplanted people with cystic fibrosis using tacrolimus, a drug-drug interaction study.

Rapid Response to Remdesivir in Hospitalised COVID-19 Patients: A Propensity Score Weighted Multicentre Cohort Study.

Drug–drug interaction: decreased posaconazole trough concentrations during concomitant flucloxacillin treatment

The influence of exocrine pancreatic function on the exposure and pharmacokinetics of ivacaftor in people with cystic fibrosis

Population Pharmacokinetics of Remdesivir and GS-441524 in Hospitalized COVID-19 Patients.

Real-life safety of PD-1 and PD-L1 inhibitors in older patients with cancer: An observational study.

Serum and Prostatic Tissue Concentrations of Cefazolin, Ciprofloxacin and Fosfomycin after Prophylactic Use for Transurethral Resection of the Prostate

Collaborators (4)

Cees van Nieuwkoop

Eleonora Swart

Brenda de Winter

Frederiek van den Bos

Make your next move.